Skip to main content
OpenTrials

Clinical trial condition

Uterine Diseases

Explore clinical trials studying Uterine Diseases. Study availability and eligibility vary by location and protocol.

3,050 public trials 697 recruiting studies
Refine in advanced search Browse all conditions

Uterine Diseases trial results

Completed

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

NCT04772989

Conditions
Advanced Solid Tumor, Blood Protein Disorders, Bronchial Neoplasms, +62 more
Locations
  • UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States
  • Mayo Clinic Jacksonville - PPDS Jacksonville, Florida, United States
  • Goshen Health System Goshen, Indiana, United States
  • Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View all 22 locations
View Trial Details
Completed

Gynecological Sentinel Lymph Nodes CEUS

NCT05105087

Conditions
Cervical Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +18 more
Locations
  • Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers

NCT03748186

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +29 more
Locations
  • Arizona Oncology - Tucson Tucson, Arizona, United States
  • UCLA Jonsson Comprehensive Cancer Center Clinical Research Unit Los Angeles, California, United States
  • Sutter Health- Palo Alto Medical Foundation San Francisco, California, United States
  • Rocky Mountain Cancer Center Aurora, Colorado, United States
View all 27 locations
View Trial Details
Completed

Trial of Maintenance With Niraparib- Uterine Serous Carcinoma

NCT04080284

Conditions
Cancer of the Endometrium, Endometrial Cancer, Endometrial Carcinoma, +14 more
Locations
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Rutgers NJ School of Medicine Newark, New Jersey, United States
  • Imbert Cancer Center Northwell Health Bay Shore, New York, United States
  • Greenlawn Cancer Institute, Northwell Health Greenlawn, New York, United States
View Trial Details
Completed

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

NCT03126110

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +82 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Washington University - Siteman Cancer Center St Louis, Missouri, United States
View all 38 locations
View Trial Details

Related conditions